Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ALKEM LABORATORIES ALEMBIC PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 42.0 26.5 158.5% View Chart
P/BV x 2.5 4.1 61.9% View Chart
Dividend Yield % 2.1 1.2 184.2%  

Financials

 ALEMBIC PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-21
ALKEM LABORATORIES
Mar-22
ALEMBIC PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,1504,068 28.3%   
Low Rs5272,671 19.7%   
Sales per share (Unadj.) Rs274.4889.4 30.9%  
Earnings per share (Unadj.) Rs56.7140.5 40.4%  
Cash flow per share (Unadj.) Rs66.0166.0 39.8%  
Dividends per share (Unadj.) Rs14.0034.00 41.2%  
Avg Dividend yield %1.71.0 165.5%  
Book value per share (Unadj.) Rs260.9722.4 36.1%  
Shares outstanding (eoy) m196.56119.57 164.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.13.8 80.7%   
Avg P/E ratio x14.824.0 61.7%  
P/CF ratio (eoy) x12.720.3 62.5%  
Price / Book Value ratio x3.24.7 68.9%  
Dividend payout %24.724.2 102.0%   
Avg Mkt Cap Rs m164,818402,868 40.9%   
No. of employees `000NANA-   
Total wages/salary Rs m10,51219,627 53.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,931106,342 50.7%  
Other income Rs m8751,627 53.8%   
Total revenues Rs m54,806107,968 50.8%   
Gross profit Rs m14,80120,380 72.6%  
Depreciation Rs m1,8353,040 60.4%   
Interest Rs m160524 30.6%   
Profit before tax Rs m13,68118,443 74.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5331,640 154.5%   
Profit after tax Rs m11,14816,803 66.3%  
Gross profit margin %27.419.2 143.2%  
Effective tax rate %18.58.9 208.3%   
Net profit margin %20.715.8 130.8%  
BALANCE SHEET DATA
Current assets Rs m25,77984,354 30.6%   
Current liabilities Rs m12,80848,053 26.7%   
Net working cap to sales %24.134.1 70.5%  
Current ratio x2.01.8 114.7%  
Inventory Days Days2342 56.0%  
Debtors Days Days265 3.6%  
Net fixed assets Rs m41,31143,245 95.5%   
Share capital Rs m393239 164.4%   
"Free" reserves Rs m50,88386,134 59.1%   
Net worth Rs m51,27686,373 59.4%   
Long term debt Rs m1,99994 2,131.0%   
Total assets Rs m67,090127,599 52.6%  
Interest coverage x86.436.2 238.6%   
Debt to equity ratio x00 3,589.6%  
Sales to assets ratio x0.80.8 96.5%   
Return on assets %16.913.6 124.1%  
Return on equity %21.719.5 111.8%  
Return on capital %26.021.9 118.4%  
Exports to sales %66.818.7 356.5%   
Imports to sales %12.70-   
Exports (fob) Rs m36,02019,924 180.8%   
Imports (cif) Rs m6,845NA-   
Fx inflow Rs m36,02019,924 180.8%   
Fx outflow Rs m6,8453,911 175.0%   
Net fx Rs m29,17516,013 182.2%   
CASH FLOW
From Operations Rs m14,63411,110 131.7%  
From Investments Rs m-8,388-14,351 58.4%  
From Financial Activity Rs m-5,9743,796 -157.4%  
Net Cashflow Rs m262580 45.3%  

Share Holding

Indian Promoters % 69.1 57.1 120.9%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 18.1 19.8 91.5%  
FIIs % 5.9 5.7 104.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 42.9 70.9%  
Shareholders   101,457 84,104 120.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    CIPLA    AUROBINDO PHARMA    



Today's Market

Sensex Trades Flat; Energy and Oil and Gas Sector Rally(10:30 am)

Asian share markets were trading on a mixed note this morning. The Nikkei surged 2.4% while the Hang Seng was down by 0.1%. The Shanghai Composite was trading higher by 0.1%.